Differential Impact of the Neutrophil-Lymphocyte Ratio on the Survival of Patients with Stage IV Gastric Cancer
暂无分享,去创建一个
Hiroaki Tanaka | K. Hirakawa | M. Ohira | T. Toyokawa | Hiroaki Tanaka | N. Kubo | K. Muguruma | Masaichi Ohira | Kosei Hirakawa | Kazuya Muguruma | Takahiro Toyokawa | Naoshi Kubo
[1] S. Clarke,et al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer , 2012, British Journal of Cancer.
[2] Yibin Kang,et al. The metastasis-promoting roles of tumor-associated immune cells , 2013, Journal of Molecular Medicine.
[3] H. Tajiri,et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma , 2012, British Journal of Cancer.
[4] S. Lim,et al. Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer , 2012, Oncology.
[5] C. Garlanda,et al. Tumor associated macrophages and neutrophils in tumor progression , 2013, Journal of cellular physiology.
[6] H. Shimada,et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer , 2010, Gastric Cancer.
[7] S. Ida,et al. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer , 2013, Journal of Gastroenterology.
[8] R. Schreiber,et al. The three Es of cancer immunoediting. , 2004, Annual review of immunology.
[9] E. Elinav,et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.
[10] M. Brennan,et al. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. , 2003, Journal of the American College of Surgeons.
[11] T. Kubota,et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer , 2012, British Journal of Cancer.
[12] M. Choi,et al. Long‐term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology , 2012, Journal of surgical oncology.
[13] M. Brennan,et al. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. , 2004, Journal of the American College of Surgeons.
[14] D. Jäger,et al. Prognostic Significance of Free Peritoneal Tumor Cells in the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with Gastric Carcinoma Undergoing Potentially Curative Resection , 2010, Annals of Surgical Oncology.
[15] K. Yamagata,et al. Liver metastasis in gastric cancer with particular reference to lymphatic advancement , 2001, Gastric Cancer.
[16] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[17] Shahid A. Khan,et al. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). , 2012, Journal of hepatology.
[18] N. Kurumatani,et al. The Prognostic Nutritional Index Predicts Long-term Outcomes of Gastric Cancer Patients Independent of Tumor Stage , 2013, Annals of Surgical Oncology.
[19] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3) , 2011, Gastric Cancer.
[20] C. Lewis,et al. Neutrophils: key mediators of tumour angiogenesis , 2009, International journal of experimental pathology.
[21] Y. Maehara,et al. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. , 1994, Anticancer research.
[22] S. Albelda,et al. Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.
[23] Y. Kodera,et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry , 2012, Gastric Cancer.
[24] Shigemi Matsumoto,et al. The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer , 2008, Oncology.
[25] P. Tran,et al. The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma , 2015, American journal of clinical oncology.
[26] D. McMillan,et al. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. , 2012, American journal of surgery.
[27] C. Antonescu,et al. Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor , 2013, Annals of Surgical Oncology.
[28] Y. Kodera,et al. Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines , 2014, Gastric Cancer.
[29] Alyssa D Gregory,et al. Tumor-associated neutrophils: new targets for cancer therapy. , 2011, Cancer research.
[30] H. Putter,et al. Value of palliative resection in gastric cancer , 2002, The British journal of surgery.